What is the Impact Factor of Molecular Diagnosis & Therapy?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Molecular Diagnosis & Therapy is 5.80, ranking in quartile Q1 of Web of Science (SCIE).

Is Molecular Diagnosis & Therapy indexed in Web of Science or Scopus?

Yes, Molecular Diagnosis & Therapy is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.812 (Q1) and an H-index of 76.

Who publishes Molecular Diagnosis & Therapy and what is the Article Processing Charge (APC)?

Molecular Diagnosis & Therapy is published by Springer International Publishing. The estimated Article Processing Charge (APC) is approximately $3,512 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Molecular Diagnosis & Therapy?

The official ISO-4 abbreviation of Molecular Diagnosis & Therapy is "MOL DIAGN THER" with common acronym "mdta". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #1,724Hybrid

Molecular Diagnosis & Therapy

Acronym:mdta

•

Abbreviation (ISO):MOL DIAGN THER

•

Identifier (ISSN):1177-1062(Print)/1179-2000(Online)

•

Publisher:Springer International Publishing

Official Website Submission Portal Compare

Clarivate IF (2026)

5.8↑ +1.4

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Molecular Diagnosis & Therapy

WoS Q1

Annual Impact Factor Metric

Current (2026):5.8

Scopus SJR & RankScopus Q1

1.812

#1,724

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

76 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation Rate2.4%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

60articles/year

40.23% Gold OA•66.1% Original Research

Aims & Scope

Molecular Diagnosis & Therapy welcomes current opinion articles on emerging or contentious issues, comprehensive narrative reviews, systematic reviews (as outlined by the PRISMA statement), original research articles (including short communications) and letters to the editor. All manuscripts are subject to peer review by international experts.

Topics Covered (Recognized by AI)

Biology98.7%Medicine95.3%Genetics93.9%Chemistry86.2%Biochemistry85.7%Internal medicine82.4%Gene73.4%Pathology52.9%Bioinformatics39.5%Cancer38%Immunology32.6%Oncology28.6%Human genetics22%Disease20.6%

Primary Research Areas

Medicine Pharmacy

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

GENETICS & HEREDITY

Rank29/192

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank50/356

IndexSCIE

JCISCIE2026

GENETICS & HEREDITY

Rank37/192

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank71/356

IndexSCIE

Category	Index	Rank	Quartile
GENETICS & HEREDITY	JCRSCIE	29/192	Q1
PHARMACOLOGY & PHARMACY	JCRSCIE	50/356	Q1
GENETICS & HEREDITY	JCISCIE	37/192	Q1
PHARMACOLOGY & PHARMACY	JCISCIE	71/356	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF5.8

Articles / Year53

Total Citations30

2025

IF4.4

Articles / Year62

Total Citations322

2024

IF4.1

Articles / Year72

Total Citations827

2023

IF4

Articles / Year57

Total Citations1,000

2022

IF4.476

Articles / Year62

Total Citations1,111

Year	Impact Factor	Articles / Year	Total Citations
2026	5.8	53	30
2025	4.4	62	322
2024	4.1	72	827
2023	4	57	1,000
2022	4.476	62	1,111
2021	4.074	66	1,765
2020	3.38	61	1,586
2019	3.058	65	1,890
2018	2.716	64	2,087
2017	—	61	2,095
2016	—	69	2,236
2015	—	55	1,137

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,724Scopus Q1SCImago Profile

Scopus Coverage:2001, 2006-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

1.812

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

5.69

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,512 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,087

3-Year Documents175

Citable Documents169

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

GeneticsQ1

Medicine (miscellaneous)Q1

Molecular MedicineQ1

PharmacologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 2.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

2区GENETICS & HEREDITY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Molecular Diagnosis & Therapy (acronym: mdta, abbr: MOL DIAGN THER, ISSN: 1177-1062) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer International Publishing in New Zealand since 2000. The periodical holds a Journal Impact Factor (JIF) of 5.80, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.812 (Q1), an H-index of 76.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 60 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,512 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.